Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
0.88%1.03%40.05x6.79x10.89x28.03x31.75x 156.57Cr
0.49%0.52%18.46x2.43x4.98x12.65x15.13x 7.74TCr
-.--%-.--%58.06x7.81x15.36x32.94x41.24x 6.09TCr
0.54%0.56%43.55x4.52x6.86x22.36x29.9x 5.75TCr
2.66%2.89%22.18x2.77x4.05x11.77x13.58x 5.59TCr
-.--%-.--%16.31x1.35x2.7x8.52x9.42x 2.48TCr
-.--%-.--%17.11x3.61x3.38x10.14x10.29x 2.08TCr
-.--%0.02%81.97x7.95x9.81x88.48x101.52x 1.99TCr
-.--%-.--%-5.03x1.86x5.65x-3.33x-3.14x 1.59TCr
-.--%-.--%-22.76x-7.35x32.67x-33.37x-32.39x 1.5TCr
-.--%-.--%-676.21x2.83x4.46x11.59x25.04x 1.28TCr
-.--%-.--%-16.2x - 582.94x-15.97x-16.13x 1.09TCr
-.--%-.--%19.9x1.75x2.94x13.6x14.4x 1.08TCr
2.91%1.88%6.26x2.61x2.85x4.27x4.32x 875.12Cr
-.--%-.--%-46.95x201.34x13.92x-58.36x-52.18x 892.35Cr
-.--%-.--%-262x - - - - 858.95Cr
-.--%-.--%43.47x - 20.43x47.25x49.03x 846.12Cr
1.39%1.68%18.56x1.25x2.13x8.85x11.79x 817.69Cr
Average 0.49% 0.48% -35.74x 16.10x 42.71x 11.14x 14.92x 2.37TCr
Weighted average by Cap. 0.6% 0.62% 0.05x 7.92x 23.11x 16.04x 20.37x
Biopharmaceuticals